Skip to main content

BioCardia, Inc.

BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000925741

In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in BioCardia, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
−1 vs. Q2 2024
Shares held
101.5K
+14.8K (+17.1%) vs. Q2 2024
Total value
$316.6K
+$88.8K (+39.0%) vs. Q2 2024
New holders
0
3 more added
Sold out
1
2 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 9 institutions
Q1 2021: 19 institutionsQ2 2021: 20 institutionsQ3 2021: 22 institutionsQ4 2021: 23 institutionsQ1 2022: 24 institutionsQ2 2022: 26 institutionsQ3 2022: 23 institutionsQ4 2022: 25 institutionsQ1 2023: 23 institutionsQ2 2023: 23 institutionsQ3 2023: 16 institutionsQ4 2023: 24 institutionsQ1 2024: 22 institutionsQ2 2024: 10 institutionsQ3 2024: 9 institutionsQ4 2024: 13 institutionsQ1 2025: 12 institutionsQ2 2025: 16 institutionsQ3 2025: 18 institutionsQ4 2025: 20 institutionsQ1 2026: 18 institutionsQ2 2026: 21 institutions
Value heldQ3 2024: $316.6K
Q1 2021: $13.5MQ2 2021: $12.3MQ3 2021: $9.01MQ4 2021: $5.78MQ1 2022: $5.49MQ2 2022: $3.10MQ3 2022: $3.17MQ4 2022: $4.87MQ1 2023: $4.09MQ2 2023: $4.43MQ3 2023: $709.6KQ4 2023: $1.37MQ1 2024: $790.8KQ2 2024: $227.8KQ3 2024: $316.6KQ4 2024: $272.2KQ1 2025: $623.8KQ2 2025: $593.2KQ3 2025: $551.9KQ4 2025: $812.3KQ1 2026: $831.1KQ2 2026: $1.65M
Institutions holding BCDA and their total value by quarter
QuarterHoldersValue
Q2 202621$1.65M
Q1 202618$831.1K
Q4 202520$812.3K
Q3 202518$551.9K
Q2 202516$593.2K
Q1 202512$623.8K
Q4 202413$272.2K
Q3 20249$316.6K
Q2 202410$227.8K
Q1 202422$790.8K
Q4 202324$1.37M
Q3 202316$709.6K
Q2 202323$4.43M
Q1 202323$4.09M
Q4 202225$4.87M
Q3 202223$3.17M
Q2 202226$3.10M
Q1 202224$5.49M
Q4 202123$5.78M
Q3 202122$9.01M
Q2 202120$12.3M
Q1 202119$13.5M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q2 2024.

Institutions holding BCDA in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Susquehanna International Group, LLP70,596$220.3K0.00%+26,039+58.4%Added
Geode Capital Management, LLC14,736$46.0K0.00%+1,715+13.2%Added
Vanguard Group Inc12,884$40.2K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,282$4.00K0.00%−1,754−57.8%Reduced
Pingora Partners LLC1,036$3.23K0.00%00.0%Unchanged
Bank of America Corp446$1.39K0.00%+2+0.5%Added
Global Retirement Partners, LLC411$1.28K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.61$1900.00%−11,128−99.5%Reduced
Morgan Stanley30$940.00%00.0%Unchanged
Royal Bank of Canada0$00.00%−26−100.0%Sold out